Prescription Justice Home Page

Prescription Justice
BLOG POSTS

10
Mar
2020
Prescription Justice President Submitted Comments to the Food and Drug Administration Regarding Section 804 Importation of Prescription Drugs
#
Gabriel Levitt, President of Prescription Justice submitted comments to the Food and Drug Administration (FDA) in response to the Notice of Proposed Rulemaking (NPRM) titled "Importation of Prescription Drugs, FDA-2019-N-5711, 84 Fed. Reg. 70796.
Read More
Tags
Prescription Pharma SUPPORT Act safe and affordable medication Relpax prescription drugs importation FDA drug pricing access to medicines public health safe and affordable medicines World Health Organization board of directors congress Medicare drug price negotiation pay-for-delay Senator Elizabeth Warren Senator Angus King medicare drug price negotiation act Bipartisan Ryan Watts trump Seniors cost-related medication nonadherence PrescriptionJustice rx big pharma report card senate petition online marketplace Congressman Mark Walker North Carolina American Patients First Wholesale Importation Utah Rep. Norman Thurston executive authority U.S. House Ways and Means Committee drug prices Senate HELP Committee HHS Secretary Alex Azar Sanders AARP Medicare Klobuchar Cummings McCain
Archives

Stay informed about news and advocacy centered on the crisis of high drug prices